XML 30 R18.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders' Equity
 6 Months Ended
Jun. 30, 2023
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Common Stock
In connection with the closing of the Business Combination, the Company authorized the issuance of 700,000,000 shares of Class A common stock, par value $0.0001 per share, 20,000,000 shares of Class B common stock, par value $0.0001 per share, and 10,000,000 shares of Class C common stock, par value $0.0001 per share. Each share of Class A common stock is entitled to one vote and each share of Class B common stock is entitled to fifty votes. Class C common stock is non-voting.
Preferred Stock
In connection with the closing of the Business Combination, the Company authorized the issuance of 50,000,000 shares of preferred stock, par value $0.0001 per share. The Board of Directors is authorized, without further stockholder approval, to issue such preferred stock in one or more series, to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each series. There were no issued and outstanding shares of preferred stock as of June 30, 2023 or December 31, 2022.
Stock-Based Compensation
Stock Options
A summary of the stock option activity under the Company’s equity incentive plans is presented below:
Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term		Aggregate
Intrinsic
Value
Balance as of December 31, 20223,976$6.20 3.80$— 
Granted51 0.61 — — 
Exercised(34)0.86 — — 
Forfeited(132)5.18 — — 
Expired(143)5.05 — — 
Balance as of June 30, 20233,718$6.25 3.11$— 
Expected to vest at June 30, 20233,718$6.25 3.11$— 
Exercisable at June 30, 20233,235$6.46 2.28$— 
As of June 30, 2023, the total share-based compensation costs not yet recognized related to unvested stock options was $1.0 million, which is expected to be recognized over the weighted-average remaining requisite service period of 1.2 years.
Restricted Stock Units
A summary of Restricted Stock Unit (“RSU”) activity is presented below:
SharesWeighted Average Grant-
Date Fair Value
Outstanding as of December 31, 20227,495$3.59 
Granted8,819 0.63 
Vested(2,052)4.03 
Forfeited(1,264)4.60 
Outstanding as of June 30, 202312,998$1.41 
As of June 30, 2023, there were approximately $12.6 million of unrecognized compensation costs related to RSUs.
Stock-Based Compensation Expense
The following table summarizes stock-based compensation cost included in the condensed consolidated statements of operations:
Three Months Ended June 30,Six Months Ended June 30,
2023202220232022
Cost of revenue, excluding depreciation and amortization$255 $2,695 $611 $3,155 
Sales and marketing318 1,391 887 2,113 
General and administrative1,612 3,782 2,154 6,380 
Research and development1
72 3,416 (273)3,576 
Total$2,257 $11,284 $3,379 $15,224 
_________________________________
(1) The negative stock-based compensation expense for the six months ended June 30, 2023 for Research and development was due to forfeitures.
RSUs settle into shares of common stock upon vesting. Upon the vesting of the RSUs, for certain employees, the Company net-settles the RSUs and withholds a portion of the shares to satisfy minimum statutory employee withholding tax requirements. Total payment of the employees’ tax obligations to the tax authorities is reflected as a financing activity within the condensed consolidated statements of cash flows.
At-The-Market Offering
On March 21, 2023, the Company filed a shelf registration statement on Form S-3 (the “Shelf Registration Statement”) under which the Company may, from time to time, sell securities in one or more offerings having an aggregate offering price of up to $150.0 million. The Shelf Registration Statement was declared effective as of April 5, 2023. On June 20, 2023, the Company entered into an At-The-Market Offering agreement with Craig-Hallum Capital Group LLC pursuant to which the Company may, from time to time, sell up to 13,266,011 shares of its Class A common stock. As of June 30, 2023, the Company sold 1,715,617 shares of its Class A common stock, at an average price of $0.52 per share, for aggregate net proceeds of $0.8 million after deducting commissions and offering expenses. The Company used the aggregate net proceeds for general corporate purposes, and the Company has 11,550,394 remaining shares available under the At-The-Market-Offering agreement.